Skip to main content
. 2009 Jul 21;100(11):2181–2187. doi: 10.1111/j.1349-7006.2009.01289.x

Figure 1.

Figure 1

In vitro combination effect in MAI Paca‐2. Target cells were treated with various concentrations of conditionally replicative adenovirus (CRAd) (0.001–10 vp/cell) combined with gemcitabine (Gem) or 5‐fluorouracil (FU) (0.025–0.250 μM or 1–256 μM). Seven days later, the cell viability was assessed. The result was analyzed with MacSynergy II with 95% confidence. (A) CRAd→Gem: antagonistic. (B) Gem→CRAd: synergistic. (C) CRAd→ 5‐FU: antagonistic. (D) 5‐FU→CRAd: synergistic.